Literature DB >> 24436540

Mental status changes postchemoembolization: the role of inflammatory response.

Daniel Wells1, Joseph Alisky2, Charles E Ray1.   

Abstract

Year:  2013        PMID： 24436540      PMCID： PMC3709929          DOI： 10.1055/s-0033-1342965

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


× No keyword cloud information.
  22 in total

1.  Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy.

Authors:  Nikolaus Kohles; Dorothea Nagel; Dietrich Jüngst; Jürgen Durner; Petra Stieber; Stefan Holdenrieder
Journal:  Tumour Biol       Date:  2011-09-20

2.  Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome.

Authors:  Sabeen Dhand; Ramona Gupta
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

3.  Cytokines and IGF-I in delirious and non-delirious acutely ill older medical inpatients.

Authors:  Dimitrios Adamis; Mary Lunn; Finbarr C Martin; Adrian Treloar; Norman Gregson; Gillian Hamilton; Alastair J D Macdonald
Journal:  Age Ageing       Date:  2009-03-05       Impact factor: 10.668

4.  Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma.

Authors:  Craig Lance; Gordon McLennan; Nancy Obuchowski; Grace Cheah; Abraham Levitin; Mark Sands; James Spain; Shyam Srinivas; Sankaran Shrikanthan; Federico N Aucejo; Richard Kim; K V Narayanan Menon
Journal:  J Vasc Interv Radiol       Date:  2011-10-08       Impact factor: 3.464

5.  Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever.

Authors:  A Castells; J Bruix; C Ayuso; C Brú; X Montanyà; L Boix; J Rodès
Journal:  J Hepatol       Date:  1995-04       Impact factor: 25.083

6.  C-Reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery.

Authors:  Basel Ramlawi; James L Rudolph; Shigetoshi Mieno; Jun Feng; Munir Boodhwani; Kamal Khabbaz; Sue E Levkoff; Edward R Marcantonio; Cesario Bianchi; Frank W Sellke
Journal:  Surgery       Date:  2006-08       Impact factor: 3.982

7.  Cytolysis following chemoembolization for hepatocellular carcinoma.

Authors:  F Paye; O Farges; M Dahmane; V Vilgrain; J F Flejou; J Belghiti
Journal:  Br J Surg       Date:  1999-02       Impact factor: 6.939

8.  Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor.

Authors:  Y Matsuda; S Kawata; T Nagase; Y Maeda; E Yamasaki; S Kiso; H Ishiguro; Y Matsuzawa
Journal:  Cancer       Date:  1994-01-01       Impact factor: 6.860

9.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

10.  Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury?

Authors:  S J Wigmore; D N Redhead; B N J Thomson; E J Currie; R W Parks; K K Madhavan; O J Garden
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.